|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12P 21/02 | |
| C12N 15/81 | |||
| C07K 14/62 |
| (11) | Number of the document | 2831262 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12872941.5 |
| Date of filing the European patent application | 2012-06-06 | |
| (97) | Date of publication of the European application | 2015-02-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/052853 |
| Date | 2012-06-06 |
| (87) | Number | WO 2013/144685 |
| Date | 2013-10-03 |
| (30) | Number | Date | Country code |
| CH12282012 | 2012-03-29 | IN |
| (72) |
GOVINDAPPA, Nagaraj, IN
SREENIVAS, Suma, IN
KANOJIA, Komal, N, IN
BASAVARAJU, Yogesh, IN
SASTRY, Kedarnath, Nanjund, IN
|
| (73) |
Biocon Limited,
20th K.M. Hosur Road, Electronic City P.O., Bangalore 560 100,
IN
|
| (54) | SECRETION OF FUNCTIONAL INSULIN GLARGINE DIRECTLY INTO THE CULTURE MEDIUM THROUGH OVER EXPRESSION OF KEX2P INTRACELLULARLY |
| SECRETION OF FUNCTIONAL INSULIN GLARGINE DIRECTLY INTO THE CULTURE MEDIUM THROUGH OVER EXPRESSION OF KEX2P INTRACELLULARLY |